ADAGE CAPITAL PARTNERS GP L.L.C. 13D and 13G filings for Gemini Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-10-27 4:30 pm Purchase | 2022-10-25 | 13D | Gemini Therapeutics, Inc. GMTX | ADAGE CAPITAL PARTNERS GP L.L.C. | 350,062 8.090% | 100,062 (+40.02%) | Filing |
| 2022-10-11 4:31 pm Purchase | 2022-09-28 | 13D | Gemini Therapeutics, Inc. GMTX | ADAGE CAPITAL PARTNERS GP L.L.C. | 250,000 5.780% | 181,739 (+266.24%) | Filing |
| 2022-02-10 08:45 am Purchase | 2021-12-31 | 13G | Gemini Therapeutics, Inc. GMTX | ADAGE CAPITAL PARTNERS GP L.L.C. | 68,261 1.580% | 68,261 (New Position) | Filing |